SDIX is a wholly owned subsidiary of OriGene Technologies, specializing in high quality, large-scale GMP antibody production. The OriGene/SDIX antibody collection includes over 10,000 antibodies with options for large scale GMP production in support of diagnostic reagent manufacturing. Products include critical reagents such as Strep A, cTnI, CRP, Apo A1, ApoB, Micro-albumin and Calibrators. SDIX also provides both polyclonal and monoclonal antibody development and production services. In the life science market, SDIX’s technology and capabilities are being used to help discover disease mechanisms, facilitate development of new drugs, and provide antibodies and assays utilized in the diagnosis of disease.